FGF23 and McCune-Albright syndrome: Patients with McCune Albright syndrome (MAS; OMIM #174800) and cutaneous-skeletal hypophosphatemia syndrome (CSHS) are associated with an increased production of FGF23 that contributes to progression of the bone lesions through an impaired phosphate and bone metabolism (1).